Midkine (13-21)

Midkine (13-21) is a synthetic peptide fragment derived from the central region of the midkine protein, an evolutionarily conserved heparin-binding growth factor known for its multifaceted roles in cell signaling, development, and tissue repair. Comprising amino acid residues 13 through 21 of the full-length midkine sequence, this peptide segment retains key structural motifs that contribute to the biological activity and receptor interactions characteristic of the parent protein. Researchers utilize such defined fragments to dissect the functional domains of midkine, enabling precise investigations into the molecular mechanisms underlying its involvement in neurogenesis, inflammation, and oncogenic processes. The availability of Midkine (13-21) as a research tool supports targeted studies that advance understanding of growth factor signaling pathways and their implications in health and disease.

Peptide structure-activity relationship studies: Midkine (13-21) serves as a critical probe in structure-activity relationship (SAR) experiments, allowing scientists to map the functional regions responsible for the protein's bioactivity. By isolating this specific segment, researchers can elucidate the contribution of the 13-21 amino acid sequence to receptor binding, downstream signaling, and the modulation of cellular responses. Such investigations are instrumental in defining minimal active motifs, which can inform the design of novel peptide analogs or inhibitors with tailored biological properties.

Receptor binding assays: The peptide fragment is widely employed in receptor binding and competition assays to characterize the interaction specificity and affinity between midkine and its known cell surface receptors, such as anaplastic lymphoma kinase (ALK) and syndecans. Utilizing labeled or modified versions of the 13-21 sequence, researchers can quantitatively assess binding kinetics, map receptor contact sites, and evaluate the competitive displacement by endogenous or synthetic ligands. These studies are essential for unraveling the molecular basis of midkine-mediated cell signaling events.

Cellular signaling pathway analysis: Midkine (13-21) is utilized to interrogate intracellular signaling cascades activated by midkine-derived peptides. By treating cultured cells with this defined fragment, investigators can monitor downstream effects on pathways such as MAPK/ERK, PI3K/Akt, or JAK/STAT, depending on the cell type and context. This approach provides valuable insight into how discrete peptide domains contribute to the modulation of proliferation, migration, or differentiation, thereby clarifying the signaling logic of midkine and related growth factors.

Peptide-protein interaction studies: The fragment is a useful tool for studying direct and indirect interactions between midkine-derived sequences and other proteins, including extracellular matrix components, co-receptors, or regulatory factors. Through techniques such as co-immunoprecipitation, surface plasmon resonance, or pull-down assays, researchers can identify novel binding partners and define interaction networks that underpin midkine's diverse biological roles. Such findings can reveal new avenues for modulating growth factor activity in experimental systems.

Peptide synthesis and analytical method development: As a well-characterized short peptide, Midkine (13-21) is frequently used as a standard or reference material in the development and validation of peptide synthesis protocols and analytical techniques. Its defined sequence and physicochemical properties make it suitable for optimizing solid-phase peptide synthesis, high-performance liquid chromatography (HPLC) separation, and mass spectrometry analysis. These technical applications support broader peptide research efforts and ensure reproducibility and accuracy in experimental workflows.

1. Cationic cell-penetrating peptides are potent furin inhibitors

2. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics

3. An interdomain binding site on HIV-1 Nef interacts with PACS-1 and PACS-2 on endosomes to down-regulate MHC-I

4. Constitutive and inflammation-dependent antimicrobial peptides produced by epithelium are differentially processed and inactivated by the commensal Finegoldia magna and the pathogen Streptococcus pyogenes

5. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists